Home › Funds › NATIONAL BANK OF CANADA /FI/ › GILD

NATIONAL BANK OF CANADA /FI/ position in GILD

GILEAD SCIENCES INC · Health Care

NATIONAL BANK OF CANADA /FI/ reported holding 1,598,539 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$238.3M, representing 0.45% of its reported portfolio and ranking #28 among its reported holdings. NATIONAL BANK OF CANADA /FI/ has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.60M sh
Reported value held$238.26M
Portfolio Weight0.45%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How NATIONAL BANK OF CANADA /FI/'s GILD position evolved

NATIONAL BANK OF CANADA /FI/ first disclosed a stake in GILD in Q3 2023 at 1,041,848 shares (US$77.1M). The position peaked in Q2 2026 at 1,946,858 shares, worth US$246.0M. Across 13 filings, NATIONAL BANK OF CANADA /FI/ increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,598,539 shares valued at US$238.3M — a reduction of -348,319 shares quarter over quarter.. Notable position changes include a 32883% increase in Q1 2024 (shares fell 6% over the following quarter), a 106% increase in Q2 2024 (shares rose 22% over the following quarter), a 129691% increase in Q2 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.04M $77.15M New
Q4 2023 2.46K $20.48M Reduce
Q1 2024 811.38K $53.52M Add
Q2 2024 1.67M $114.74M Add
Q3 2024 1.67M $139.93M Hold
Q4 2024 1.52M $140.25M Reduce
Q1 2025 1.63M $182.22M Add
Q2 2025 1.29M $142.74M Reduce
Q3 2025 1.45M $161.14M Add
Q4 2025 1.90M $233.21M Add
Q1 2026 1.50K $20.91M Reduce
Q2 2026 1.95M $245.97M Add
Q3 2026 1.60M $238.26M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include BlackRock Inc (US$18.67B), Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has NATIONAL BANK OF CANADA /FI/ held GILD?

NATIONAL BANK OF CANADA /FI/ has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is NATIONAL BANK OF CANADA /FI/'s current position in GILD?

As of Q3 2026, NATIONAL BANK OF CANADA /FI/ holds 1.60M shares of GILD (GILEAD SCIENCES INC), valued at $238.26M, representing 0.45% of its reported portfolio and ranking #28.

Has NATIONAL BANK OF CANADA /FI/ been buying or selling GILD?

In the latest 13F filing (Q3 2026), NATIONAL BANK OF CANADA /FI/ reduced its position in GILD. The position peaked in Q2 2026 at 1.95M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include BlackRock Inc, Fidelity Management & Research (FMR), Invesco Ltd, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.